X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (826) 826
Publication (49) 49
Book / eBook (5) 5
Book Review (5) 5
Magazine Article (4) 4
Web Resource (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (789) 789
myelodysplastic syndromes - physiopathology (476) 476
hematology (350) 350
male (340) 340
female (328) 328
aged (286) 286
myelodysplastic syndromes (285) 285
middle aged (273) 273
index medicus (271) 271
adult (216) 216
oncology (211) 211
myelodysplastic syndrome (199) 199
prognosis (159) 159
myelodysplastic syndromes - genetics (147) 147
acute myeloid-leukemia (146) 146
myelodysplastic syndromes - pathology (146) 146
myelodysplastic syndromes - therapy (129) 129
leukemia (120) 120
aged, 80 and over (117) 117
myelodysplastic syndromes - drug therapy (113) 113
adolescent (97) 97
myelodysplastic syndromes - diagnosis (94) 94
myelodysplastic syndromes - complications (93) 93
animals (86) 86
bone marrow - pathology (80) 80
apoptosis (74) 74
hematopoiesis (74) 74
treatment outcome (70) 70
cancer (69) 69
child (67) 67
anemia (63) 63
classification (63) 63
colony-stimulating factor (63) 63
myelodysplastic syndromes - blood (63) 63
leukemia, myeloid, acute - physiopathology (62) 62
risk factors (59) 59
bone-marrow (52) 52
hematology, oncology and palliative medicine (50) 50
mutation (50) 50
acute myelogenous leukemia (49) 49
child, preschool (49) 49
expression (48) 48
research (48) 48
acute myeloid leukemia (47) 47
disease progression (47) 47
medicine & public health (47) 47
survival analysis (47) 47
acute disease (45) 45
bone marrow (45) 45
myelodysplastic syndromes - classification (44) 44
retrospective studies (44) 44
transplantation (44) 44
mds (43) 43
medicine, general & internal (43) 43
follow-up studies (42) 42
therapy (42) 42
bone marrow - physiopathology (41) 41
care and treatment (41) 41
chromosome aberrations (41) 41
myelodysplasia (39) 39
myelodysplastic syndromes - metabolism (39) 39
diagnosis (38) 38
mice (38) 38
myelodysplastic syndromes - epidemiology (38) 38
myelodysplastic syndromes - immunology (37) 37
hematopoietic stem cells - pathology (36) 36
infant (36) 36
analysis (35) 35
antineoplastic agents - therapeutic use (35) 35
leukemia, myeloid, acute - genetics (35) 35
cells (34) 34
myelodysplastic syndromes - etiology (34) 34
scoring system (34) 34
stem-cell transplantation (34) 34
young adult (33) 33
cells, cultured (32) 32
diagnosis, differential (32) 32
hematopoietic stem cell transplantation (32) 32
karyotyping (32) 32
leukemia - physiopathology (32) 32
stem cells (32) 32
bone-marrow-transplantation (31) 31
immunosuppressive agents - therapeutic use (31) 31
medicine, research & experimental (30) 30
pharmacology & pharmacy (30) 30
bone marrow cells - pathology (29) 29
hemic and lymphatic diseases (29) 29
survival (29) 29
chronic myelomonocytic leukemia (28) 28
disease (28) 28
health aspects (28) 28
myelodysplastic syndromes - mortality (28) 28
age factors (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
hematopoietic stem cells (27) 27
immunology (27) 27
leukemia, myeloid - physiopathology (27) 27
leukemia, myeloid, acute - pathology (27) 27
pathology (27) 27
remission induction (27) 27
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (768) 768
French (29) 29
Japanese (23) 23
Chinese (9) 9
German (4) 4
Polish (3) 3
Russian (3) 3
Spanish (3) 3
Dutch (2) 2
Hungarian (2) 2
Italian (2) 2
Portuguese (2) 2
Czech (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2011, Volume 118, Issue 24, pp. 6239 - 6246
Journal Article
Nature, ISSN 0028-0836, 07/2015, Volume 523, Issue 7559, pp. 183 - 188
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, pp. e0172147 - e0172147
The risk and clinical significance of cardiac iron overload due to chronic transfusion varies with the underlying disease. Cardiac iron overload shortens the... 
MORTALITY | SURVIVAL | RESONANCE | MORBIDITY | CHELATION-THERAPY | DEPENDENT PATIENTS | MULTIDISCIPLINARY SCIENCES | DISEASE | ACCUMULATION | BETA-THALASSEMIA | CHILDREN | Heart - physiopathology | Thalassemia - blood | Myelodysplastic Syndromes - physiopathology | Anemia, Sickle Cell - physiopathology | Humans | Middle Aged | Male | Myelodysplastic Syndromes - blood | Iron Overload - physiopathology | Iron Overload - blood | Blood Transfusion | Iron Chelating Agents | Myocardium - metabolism | Adolescent | Adult | Female | Anemia, Sickle Cell - blood | Thalassemia - physiopathology | Child | Iron - blood | Sickle cell anemia | Cardiac patients | Analysis | Thalassemia | Iron | Research | Health aspects | Myelodysplastic syndromes | Blood transfusions | Heart | Erythropoiesis | Pediatrics | Transferrin | Nuclear magnetic resonance--NMR | Transfusion | Laboratories | Liver | Ferritin | Disorders | Macrophages | Blood | Myelodysplastic syndrome | Red blood cells | Chelation | Hemoglobin | Sickle cell disease | Heart diseases | Age | Life expectancy | Hematology | Anemia | Research & development--R&D | Magnetic resonance | Inflammation | Patients | Coronary artery disease | Chromatography | Hospitals | Life span | Scientific imaging | Hepcidin | Mass spectrometry | Index Medicus | Life Sciences | Human health and pathology | Research & development | Nuclear magnetic resonance | R&D | NMR
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2016, Volume 11, Issue 6, p. e0157279
Background In many elderly patients with anemia, a specific cause cannot be identified. This study investigates whether erythropoietin levels are... 
IMPACT | UNEXPLAINED ANEMIA | MULTIDISCIPLINARY SCIENCES | RISK | COHORT | QUALITY-OF-LIFE | EQUATION | Anemia, Iron-Deficiency - physiopathology | Anemia - blood | Vitamin B 12 Deficiency - blood | Humans | Middle Aged | Male | Hematologic Tests | Myelodysplastic Syndromes - blood | Renal Insufficiency, Chronic - complications | Anemia, Iron-Deficiency - blood | Anemia - physiopathology | Erythropoietin - blood | Vitamin B 12 Deficiency - complications | Aged, 80 and over | Female | Renal Insufficiency, Chronic - diagnosis | Retrospective Studies | Anemia - etiology | Folic Acid Deficiency - blood | Myelodysplastic Syndromes - physiopathology | Glomerular Filtration Rate | Comorbidity | Vitamin B 12 Deficiency - diagnosis | Anemia - diagnosis | Hemoglobins - metabolism | Linear Models | Vitamin B 12 Deficiency - physiopathology | Biomarkers - blood | Myelodysplastic Syndromes - complications | Renal Insufficiency, Chronic - physiopathology | Folic Acid Deficiency - physiopathology | Renal Insufficiency, Chronic - blood | Myelodysplastic Syndromes - diagnosis | Folic Acid Deficiency - complications | Anemia, Iron-Deficiency - diagnosis | Aged | Folic Acid Deficiency - diagnosis | Chronic Disease | Elderly people | Health sciences | Erythropoietin | Laboratories | Pathogenesis | Medical records | Systematic review | Iron | Vitamin B12 | Epidemiology | Myelodysplastic syndrome | Folic acid | Regression models | Etiology | Hemoglobin | Chronic illnesses | Nutrient deficiency | Kidneys | Hematology | Epidermal growth factor receptors | Anemia | Mortality | Regression analysis | Patients | Glomerular filtration rate | Medicine | Hypoxia | Kidney diseases | Electronic health records | Elderly | Geriatrics
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 02/2011, Volume 162, Issue 4, pp. 792 - 805
Therapy‐related myeloid neoplasms (t‐MNs) are serious long‐term consequences of cytotoxic treatments for an antecedent disorder. t‐MNs are observed after... 
alkylating agents | stem cell transplantation | antimetabolites | therapy‐related myeloid neoplasms | therapy‐related myelodysplastic syndrome | therapy‐related acute myeloid leukaemia | granulocyte‐colony stimulating factor | genetic susceptibility | topoisomerase‐II‐inhibitors | ionizing radiation | topoisomerase-II-inhibitors | granulocyte-colony stimulating factor | therapy-related acute myeloid leukaemia | therapy-related myeloid neoplasms | therapy-related myelodysplastic syndrome | ACUTE MYELOMONOCYTIC LEUKEMIA | COLONY-STIMULATING FACTOR | DNA-TOPOISOMERASE-II | CONVENTIONAL CARE REGIMENS | LI-FRAUMENI-SYNDROME | ACUTE LYMPHOBLASTIC-LEUKEMIA | CAUSE NOONAN-SYNDROME | PHARMACOLOGY & PHARMACY | STEM-CELL TRANSPLANTATION | ACUTE PROMYELOCYTIC LEUKEMIA | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease | Myelodysplastic Syndromes - physiopathology | Prognosis | Humans | Hematopoietic Stem Cell Transplantation | Radiotherapy - adverse effects | Myelodysplastic Syndromes - therapy | Animals | Antineoplastic Agents - adverse effects | Neoplasms, Second Primary - chemically induced | Neoplasms, Second Primary - therapy | Myelodysplastic Syndromes - chemically induced | Myelodysplastic Syndromes - genetics | Neoplasms, Second Primary - physiopathology | Neoplasms, Second Primary - genetics | Leukemia, Myeloid, Acute - chemically induced | Leukemia, Myeloid, Acute - physiopathology | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - genetics | Bone marrow | Cytotoxicity | Transplants & implants | Mortality | Tumors | Reviews
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 10/2014, Volume 51, Issue 10, pp. 689 - 697
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2017, Volume 12, Issue 9, pp. e0184079 - e0184079
Journal Article